Company Overview
About Inflow
Inflow is a London-based digital health company providing a science-based self-management app for adults with ADHD — backed with $16.7 million raised including an $11 million Series A led by Octopus Ventures in 2023 — delivering cognitive behavioral therapy (CBT), psychoeducation, ADHD coaching, and evidence-based habit management tools through a mobile app that helps adults understand and manage their ADHD without relying exclusively on medication. Founded in 2020, Inflow acquired Lina Health in 2022 to expand telehealth capabilities and has achieved 100,000+ downloads, serving adults who are newly diagnosed, managing ADHD alongside medication, or seeking non-pharmacological coping strategies.
Business Model & Competitive Advantage
Inflow's therapeutic content library covers the specific challenges adults with ADHD face: executive function deficits (procrastination, task initiation, time management), emotional dysregulation, rejection sensitive dysphoria (RSD), and working memory limitations — each addressed through module-based CBT exercises, psychoeducation, and practical tools. The structured program approach (90+ days of evidence-based content) distinguishes Inflow from generic meditation apps that provide insufficient ADHD-specific structure. Community features (peer support groups within the app) address the social isolation that many adults with ADHD experience when traditional productivity and time management approaches consistently fail. The Lina Health acquisition added licensed therapist telehealth consultations for users who need clinical support beyond self-help.
Competitive Landscape 2025–2026
In 2025, Inflow competes in the digital mental health and ADHD management market with Done (ADHD telehealth, online diagnosis and prescriptions, $30M raised), Cerebral (mental health platform, $300M raised), and Headspace (meditation and mental health, $215M raised) for adult ADHD digital health spending. ADHD diagnosis rates have grown significantly among adults (estimated 8 million+ undiagnosed adults in the US) as awareness increased and telehealth diagnosis became more accessible. The controlled substance prescription challenges for ADHD medication (amphetamine shortage, stimulant prescribing restrictions) increase demand for behavioral and CBT-based ADHD management tools. Octopus Ventures' lead reflects UK venture investment in digital health. The 2025 strategy focuses on Inflow's employer benefit channel (ADHD management as a workplace wellness benefit), expanding the coaching subscription, and building clinical partnerships for the NHS digital mental health agenda.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Inflow is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
S2
S2 is an AI-powered security platform focused on vulnerability discovery and attack surface management for enterprise security teams. The company's platform combines automated scanning, AI-powered ana
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Compare Inflow with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Inflow? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Inflow Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Inflow vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →